New rat model for attention deficit hyperactive disorder (ADHD)

Comparative Medicine

Volumn 51, Issue 3, 2001, Pages 245-251

  Kamimura, E ^a   Ueno, Y ^a   Tanaka, S ^a   Sawa, H ^a   Yoshioka, M ^a   Ueno, K I ^a   Inoue, T ^a   Li, X ^a   Koyama, T ^a   Ishikawa, R ^a   Nagashima, K ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CONTROLLED STUDY; FEMALE; GENE TRANSFER; GENETIC LINKAGE; HYPERACTIVITY; INHERITANCE; MALE; MAZE TEST; MOTOR ACTIVITY; NONHUMAN; RAT; WORKING MEMORY;

ANIMALS; ANIMALS, CONGENIC; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ANIMAL; CIRCADIAN RHYTHM; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; FEMALE; GENES, RECESSIVE; HUMANS; MALE; MAZE LEARNING; MEMORY; MOTOR ACTIVITY; NERVOUS SYSTEM; RATS; RATS, INBRED LEC; RATS, MUTANT STRAINS; RATS, WISTAR;

EID: 0034917413     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Problems in the management of attention-deficit-hyperactivity disorder
2. Genetic basis of attention deficit and hyperactivity
3. Female transgenic mice carrying multiple copies of the human gene for S100 beta are hyperactive
4. Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II
5. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors
6. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities
7. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model
8. Absence of linkage of apparently single gene mediated ADHD with the human syntenic region of the mouse mutant Coloboma
9. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation
10. Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission
11. Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder
12. The acallosal mouse strain I/LnJ: A putative model of ADHD?
13. Proposed animal model of attention deficit hyperactivity disorder
14. Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder
15. Behavioural hyperactivity in rats following postnatal exposure to sub-toxic doses of polychlorinated biphenyl congeners 153 and 126
16. Alleviation of x-irradiation-based deficit in memory-based learning by D-amphetamine: Suggestions for attention deficit-hyperactivity disorder
17. Two new inbred rat strains derived from SHR: WKHA, hyperactive, and WKHT, hypertensive, rats
18. Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains
19. Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of attention-deficit/hyperactivity disorder
20. 3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder
21. Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD
22. A quantitative cytochrome oxidase mapping study, cross-regional and neurobehavioural correlations in the anterior forebrain of an animal model of attention deficit hyperactivity disorder
23. Reduced transduction mechanisms in the anterior accumbal interface of an animal model of attention-deficit hyperactivity disorder
24. The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat as studied in vitro by the superfusion slice technique
25. Remodeling of neural networks in the anterior forebrain of an animal model of hyperactivity and attention deficits as monitored by molecular imaging probes
26. Early androgen treatment decreases cognitive function and catecholamine innervation in an animal model of ADHD
27. Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder: Acquisition and performance of the DRL-60s test
28. New mutation causing hereditary hepatitis in the laboratory rat
29. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene
30. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride
31. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine
32. Differential role of nucleus accumbens and caudate-putamen in mediating the effect of nomifensine and methamphetamine on ambulation and rearing of rats in the open-field test
33. Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist betacarbolines
34. Differential effects of intracerebroventricular AF64A injection, nucleus basalis of Meynert lesion, and scopolamine on place navigation and open-field behavior of rats
35. Excitatory amino acid antagonists and memory: Effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks
36. Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice
37. U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice
38. Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats
39. Naloxone modulates the behavioral effects of cholinergic agonists and antagonists
40. Dopaminergic involvement in attention. A novel animal model
41. Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task
42. Spontaneous alternation behavior: An animal model for obsessive-compulsive disorder?
43. Serotonergic agents restore appropriate decision-making in neonatal rats displaying dopamine D1 receptor-mediated vacillatory behavior